Patents by Inventor Lucia B. Rothman-Denes

Lucia B. Rothman-Denes has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 8137911
    Abstract: The present invention provides methods, compositions and kits for using an RNA polymerase for making transcription products corresponding to a target sequence by obtaining single-stranded DNA transcription substrates that comprise a single-stranded promoter that is operably joined to a single-stranded target sequence. The invention has broad applicability for research, diagnostic and therapeutic applications, such as preparing cDNA corresponding to full-length mRNA, making sense or anti-sense probes, detecting gene- or organism-specific sequences, cloning, cell signaling or making RNA for use in RNAi.
    Type: Grant
    Filed: November 21, 2003
    Date of Patent: March 20, 2012
    Assignee: CellScript, Inc.
    Inventors: Gary A. Dahl, Jerome J. Jendrisak, Elena K. Davydova, Lucia B. Rothman-Denes, Svetalana Y. Gerdes
  • Patent number: 7838270
    Abstract: The present invention comprises novel methods, compositions and kits that use N4 vRNAP deletion mutants to detect and quantify analytes comprising one or multiple target nucleic acid sequences, including target sequences that differ by as little as one nucleotide or non-nucleic acid analytes, by detecting a target sequence tag that is joined to an analyte-binding substance. The method consists of an annealing process, a DNA ligation process, an optional DNA polymerase extension process, a transcription process, and, optionally, a detection process.
    Type: Grant
    Filed: December 23, 2003
    Date of Patent: November 23, 2010
    Assignee: The University of Chicago
    Inventors: Elena K. Davydova, Krystyna Maria Kazmierczak, Lucia B. Rothman-Denes
  • Patent number: 7452705
    Abstract: A histidine-tagged, deletion mutant of bacteriophage N4-coded, virion RNA polymerase (mini-vRNAP) which is active has been developed. The his-tagged mini-vRNAP has been cloned under the control of the pBAD promoter, is stable and is purified in a single step yielding large amounts (10 mg/liter of E. coli expressing cells). This RNA polymerase uses single-stranded DNA containing 17 bases (the promoter) upstream of the transcribed regions as a template. In the presence of E. coli SSB protein, it transcribes this template efficiently, providing a unique system to synthesize RNAs of the desired sequence using single-stranded DNA templates. The enzyme incorporates derivatized nucleoside triphosphates with high efficiency. A mutant of mini-vRNAP has been generated that incorporates deoxynucleoside triphosphates. In addition, the inventors have developed an in vivo system to express RNAs and proteins under mini vRNA polymerase promoter control.
    Type: Grant
    Filed: May 22, 2002
    Date of Patent: November 18, 2008
    Assignee: The University of Chicago
    Inventors: Krystyna M. Kazmierczak, Elena K. Davydova, Lucia B. Rothman-Denes
  • Publication number: 20040191812
    Abstract: The present invention comprises novel methods, compositions and kits that use N4 vRNAP deletion mutants to detect and quantify analytes comprising one or multiple target nucleic acid sequences, including target sequences that differ by as little as one nucleotide or non-nucleic acid analytes, by detecting a target sequence tag that is joined to an analyte-binding substance.
    Type: Application
    Filed: December 23, 2003
    Publication date: September 30, 2004
    Inventors: Elena K. Davydova, Lucia B. Rothman-Denes, Gary A. Dahl, Svetlana Y. Gerdes, Jerome J. Jendrisak
  • Publication number: 20040171041
    Abstract: The present invention provides methods, compositions and kits for using an RNA polymerase for making transcription products corresponding to a target sequence by obtaining single-stranded DNA transcription substrates that comprise a single-stranded promoter that is operably joined to a single-stranded target sequence. The invention has broad applicability for research, diagnostic and therapeutic applications, such as preparing cDNA corresponding to full-length mRNA, making sense or anti-sense probes, detecting gene- or organism-specific sequences, cloning, cell signaling or making RNA for use in RNAi.
    Type: Application
    Filed: November 21, 2003
    Publication date: September 2, 2004
    Inventors: Gary A. Dahl, Jerome J. Jendrisak, Elena K. Davydova, Lucia B. Rothman-Denes, Svetlana Y. Gerdes
  • Publication number: 20030096349
    Abstract: A histidine-tagged, deletion mutant of bacteriophage N4-coded, virion RNA polymerase (mini-vRNAP) which is active has been developed. The his-tagged mini-vRNAP has been cloned under the control of the pBAD promoter, is stable and is purified in a single step yielding large amounts (10 mg/liter of E. coli expressing cells). This RNA polymerase uses single-stranded DNA containing 17 bases (the promoter) upstream of the transcribed regions as a template. In the presence of E. coli SSB protein, it transcribes this template efficiently, providing a unique system to synthesize RNAs of the desired sequence using single-stranded DNA templates. The enzyme incorporates derivatized nucleoside triphosphates with high efficiency. A mutant of mini-vRNAP has been generated that incorporates deoxynucleoside triphosphates. In addition, the inventors have developed an in vivo system to express RNAs and proteins under mini vRNA polymerase promoter control.
    Type: Application
    Filed: May 22, 2002
    Publication date: May 22, 2003
    Applicant: The University of Chicago
    Inventors: Krystyna M. Kazmierczak, Elena K. Davydova, Lucia B. Rothman-Denes